AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Busfor 10mg8/31/2023 ![]() ![]() The Joint Commission on Accreditation of Health Care Organization (JCAHO) proclaimed that pain assessment be recorded as the ‘fifth vital sign’, despite the fact that pain is a symptom and not really a measurable sign. To improve pain management, the Veterans Health Administration launched the ‘Pain As the 5th Vital Sign’ initiative in 1999, requiring a pain intensity rating (0 to 10) at all clinical encounters (see ). The increase in prescriptions for opioid analgesics has been fueled, in part, by the focus on pain as the fifth vital sign. Reproduced from ‘Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities’. ![]() Rates of opioid sales and opioid substance abuse treatment admissions in the United States, 1999–2010. ![]() There is concern that large quantities of opioids are prescribed to people who do not require them for medical indications (see ). Some of the increased demand for prescription opioid analgesics for chronic pain is from people who use them nonmedically (without a prescription or for recreational purposes), or sell them, or get the opioids from multiple prescribers at the same time. The increase in prescriptions of opioid analgesics for pain relief has also led to an increase in the number of deaths due to opioid overdose. The US Centers for Disease Control and Prevention (CDC) estimated that providers prescribe almost 2–3 times more opioid analgesics than are required for the entire duration of therapy, and the providers that prescribe most of these opioids are physicians. In fact, 4% of US adults are taking chronic opioid therapy, chiefly for noncancer pain. The dispensing of opioid analgesics has grown exponentially in the last 10 years from nearly 149 million prescriptions in early 2003 to 207 million in 2013 (see ). Healthcare providers in the US wrote more than 259 million prescriptions for opioid analge-sics in 2012 (see ) prescription rates per capita were highest in southern US states ( Figure 1). Opioids are the major pain relieving medications prescribed for malignant and nonmalignant pain in the US. Size and scope of the problem of opioid use and abuse The prevalence of constipation in patients receiving opioids for chronic non-cancer pain ranges from 41 to 81%. OIC is the most common adverse effect since tolerance does not develop over the long term, in contrast to symptoms such as nausea, vomiting and sedation, OIC can be experienced at any point of time after initiation of opioid analgesics.Īmong the indications for chronic noncancer pain, opioids are used for conditions such as pain following orthopedic and other surgeries, back pain, osteoarthritis, peripheral neuropathy, chronic back pain, refractory headache and fibromyalgia. Opioid induced bowel dysfunction (OBD) refers to the constellation of gastrointestinal adverse effects of opioids: nausea, vomiting, opioid induced constipation (OIC), abdominal cramping, bloating and abdominal pain. ![]() Apart from other adverse effects of chronic opioid use, gastrointestinal adverse effects are among the most frequently encountered. Opioid analgesics are one of the most commonly prescribed classes of medication for chronic nonmalignant pain. ![]()
0 Comments
Read More
Leave a Reply. |